retatrutide after VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide—A Game Changer in Obesity

Under medical supervision, patients may experience similar weight loss outcomes as injections from oral semaglutide, though results still vary based on individual lifestyle factors and treatment plans

Wang MTM, Bhatti MT, Danesh-Meyer HV (2022) Idiopathic intracranial hypertension: pathophysiology, diagnosis and management

When you increase your dose too quickly, you dramatically increase the likelihood of experiencing severe gastrointestinal side effects

An individual stays on the starting dose for a minimum of 4 weeks

Variations in electronic health recordbased definitions of diabetic retinopathy cohorts: a literature review and quantitative analysis

Many patients do not realize that dehydration is a GLP-1 side effect, but obesity medicine physicians are routinely screening for dehydration at follow-up visits, says Reema Dbouk, MD, assistant professor of medicine at Emory University in Atlanta and a spokesperson for The Obesity Society